新和成，净利大涨63.5%，PPS量价齐升，适时推进剩余8000吨项目

Core Viewpoint - The company Xinhecheng reported a significant increase in revenue and profit for the first half of 2025, indicating strong performance in the pharmaceutical and chemical sectors, as well as growth in new materials and nutritional products [2]. Financial Performance - For the first half of 2025, the company achieved a revenue of 11.1 billion yuan, a year-on-year increase of 12.8%, and a net profit attributable to shareholders of 3.6 billion yuan, up 63.5% year-on-year [2]. - The operating cash flow net amount reached 3.243 billion yuan, reflecting a growth of 51.65% [2]. - In Q2 2025, revenue was 5.66 billion yuan, with a year-on-year increase of 5.9%, and a net profit of 1.72 billion yuan, up 29.1% [2]. Sales and Market Opportunities - The company is actively seizing market opportunities in key areas such as nutritional products, new materials, and fragrances, while promoting the market expansion of new products like HA series and tryptophan [2]. - The pharmaceutical and chemical sector remains the main revenue driver, generating 10.016 billion yuan, accounting for 90.23% of total revenue, with a year-on-year growth of 10.34% [4]. Product Segmentation - Nutritional products, as a core business pillar, generated 7.199 billion yuan, representing 64.86% of total revenue, with a year-on-year growth of 7.78% and a gross margin of 47.79%, up 11.93 percentage points [4]. - The fragrance and flavor business achieved revenue of 2.105 billion yuan, accounting for 18.96% of total revenue, with a year-on-year increase of 9.35% and a gross margin of 54.01%, up 4.32 percentage points [4]. - The new materials segment reported revenue of 1.038 billion yuan, a year-on-year increase of 43.75%, with plans for further expansion based on market demand [4]. Project Development - Most projects are progressing steadily, including the joint venture with Sinopec for an 18,000-ton/year liquid methionine project, which has entered trial production [5]. - The Tianjin nylon new materials project has completed compliance approvals and is expected to be operational by 2027 [5].